E. David Crawford

Title(s)Clinical Professor, Urology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now. JCO Oncol Pract. 2025 Jun; 21(6):747-753. Shore N, Nielsen SM, Esplin ED, Antonarakis ES, Barata PC, Beer TM, Beltran H, Bryce A, Cookson MS, Crawford ED, Dorff TB, George DJ, Heath EI, Helfand BT, Hussain M, Mckay RR, Morgans AK, Morris MJ, Paller CJ, Ross AE, Sartor O, Shen J, Sieber P, Smith MR, Wise DR, Armstrong AJ. PMID: 39700441; PMCID: PMC12162241.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    2. Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. Cancer. 2025 Jan 01; 131(1):e35612. Bryce AH, Agarwal N, Beltran H, Hussain MH, Sartor O, Shore N, Antonarakis ES, Armstrong AJ, Calais J, Carducci MA, Dorff TB, Efstathiou JA, Gleave M, Gomella LG, Higano C, Hope TA, Iagaru A, Morgans AK, Morris DS, Morris MJ, Petrylak DP, Reiter RE, Rettig MB, Ryan CJ, Sellinger SB, Spratt DE, Srinivas S, Tagawa ST, Taplin ME, Yu EY, Zhang T, McKay RR, Koo PJ, Crawford ED. PMID: 39616467; PMCID: PMC11694557.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    3. Editorial Comment on "Should Military Veterans Be Classified as High Risk for Prostate Cancer Screening? A Systematic Review and Meta-analysis". Urology. 2025 03; 197:222-223. David Crawford E, Crosby M. PMID: 39510214.
      View in: PubMed   Mentions:    Fields:    
    4. Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis. Cancer Med. 2024 Nov; 13(21):e70029. Uemura M, Kikukawa H, Hashimoto Y, Uemura H, Mizokami A, Kato M, Matsushima H, Kosaka T, Nakamura M, Fukasawa S, Smith MR, Tombal B, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kakiuchi H, Akiyama M, Li R, Kuss I, Joensuu H, Suzuki H. PMID: 39527466; PMCID: PMC11552649.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    5. Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study. Eur Urol. 2024 Oct; 86(4):329-339. Saad F, Hussain MHA, Tombal B, Fizazi K, Sternberg CN, Crawford ED, Nordquist LT, Bögemann M, Tutrone R, Shore ND, Belkoff L, Fralich T, Jhaveri J, Srinivasan S, Li R, Verholen F, Kuss I, Smith MR. PMID: 38644146.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    6. Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1. JU Open Plus. 2024 Apr; 2(4). Crawford ED, Bryce AH, Hussain MH, Agarwal N, Beltran H, Cooperberg MR, Petrylak DP, Shore N, Spratt DE, Tagawa ST, Antonarakis ES, Aparicio AM, Armstrong AJ, Boike TP, Calais J, Carducci MA, Chapin BF, Cookson MS, Davis JW, Dorff T, Eggener SE, Feng FY, Gleave M, Higano C, Iagaru A, Morgans AK, Morris M, Murray KS, Poage W, Rettig MB, Sartor O, Scher HI, Sieber P, Small E, Srinivas S, Yu EY, Zhang T, Koo PJ. PMID: 38774466; PMCID: PMC11108024.
      View in: PubMed   Mentions: 2  
    7. Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU Open Plus. 2024 Apr; 2(4). Bryce AH, Crawford ED, Agarwal N, Hussain MH, Beltran H, Cooperberg MR, Petrylak DP, Shore N, Spratt DE, Tagawa ST, Antonarakis ES, Aparicio AM, Armstrong AJ, Boike TP, Calais J, Carducci MA, Chapin BF, Cookson MS, Davis JW, Dorff T, Eggener SE, Feng FY, Gleave M, Higano C, Iagaru A, Morgans AK, Morris M, Murray KS, Poage W, Rettig MB, Sartor O, Scher HI, Sieber P, Small E, Srinivas S, Yu EY, Zhang T, Koo PJ. PMID: 38774467; PMCID: PMC11107999.
      View in: PubMed   Mentions: 2  
    8. Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist. J Urol. 2024 03; 211(3):482. Garnick MB, Hafron J, Crawford ED. PMID: 38179977.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Editorial Comment. Urol Pract. 2024 01; 11(1):161-162. Garnick MB, Crawford ED. PMID: 38117961.
      View in: PubMed   Mentions:    Fields:    
    10. Reply by Authors. Urol Pract. 2024 01; 11(1):30-31. Crawford ED, Garnick MB, Eckel RH, Miner MM, Freedland SJ, Pachynski RK, Wassersug RJ, Rosenberg MT, Walker LM, Fairman C, Curley T, Crosby M, Lin PH, Hafron JM. PMID: 38051218.
      View in: PubMed   Mentions:    Fields:    
    11. A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group. Urol Pract. 2024 01; 11(1):18-29. Crawford ED, Garnick MB, Eckel RH, Miner MM, Freedland SJ, Pachynski RK, Wassersug RJ, Rosenberg MT, Walker LM, Fairman C, Curley T, Crosby M, Lin PH, Hafron JM. PMID: 37917591; PMCID: PMC12721625.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Editorial Comment. Urol Pract. 2023 11; 10(6):546. Crawford ED, Vickers JA. PMID: 37856723.
      View in: PubMed   Mentions:    Fields:    
    13. Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist. J Urol. 2024 01; 211(1):63-70. Crawford ED, Hafron JM, Debruyne F, Wallis C, Chang S, Garnick MB. PMID: 37796473; PMCID: PMC12721696.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. Cases in the management of prostate cancer: the addition of darolutamide to androgen deprivation therapy and docetaxel in a 55-year-old man with metastatic hormone-sensitive prostate cancer. Clin Adv Hematol Oncol. 2022 07; 20 Suppl 14(7):1-8. Crawford ED. PMID: 35905311.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Editorial Comment. J Urol. 2022 08; 208(2):324. Crawford ED. PMID: 35510427.
      View in: PubMed   Mentions:    Fields:    
    16. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022 03 24; 386(12):1132-1142. Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B, ARASENS Trial Investigators. PMID: 35179323; PMCID: PMC9844551.
      View in: PubMed   Mentions: 412     Fields:    Translation:HumansCTClinical Trials
    17. Editorial Comment. J Urol. 2021 11; 206(5):1175. Crawford ED. PMID: 34383587.
      View in: PubMed   Mentions:    Fields:    
    18. Editorial Comment. J Urol. 2021 10; 206(4):958. Crawford ED. PMID: 34259538.
      View in: PubMed   Mentions:    Fields:    
    19. Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data. J Urol. 2021 02; 205(2):554-560. Crawford ED, Hafron JM, Tagawa ST, Twardowski PW, Harris RG, Moul JW, Keane TE, Concepcion RS, Higano CS, Gordan LN, Petrylak DP, Cross CK, Kader AK, Shore ND. PMID: 33090917.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Darolutamide: An Evidenced-Based Review of Its Efficacy and Safety in the Treatment of Prostate Cancer. Cancer Manag Res. 2020; 12:5667-5676. Crawford ED, Stanton W, Mandair D. PMID: 32765070; PMCID: PMC7367726.
      View in: PubMed   Mentions: 12  
    21. The role of FSH and LH in prostate cancer and cardiometabolic comorbidities. Can J Urol. 2020 04; 27(2):10167-10173. Crawford ED, Schally AV. PMID: 32333736.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    22. The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data. J Urol. 2020 Apr; 203(4):743-750. Crawford ED, Twardowski PW, Concepcion RS, Hafron JM, Harris RG, Moul JW, Gordan LN, Petrylak DP, Atkinson SN, Boldt-Houle DM, Keane TE, Higano CS, Henderson RJ, Kader AK, Hussain MH, Shore ND. PMID: 31580749.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. The effect of bicycle riding on serum prostate specific antigen levels. J Urol. 1996 Jul; 156(1):103-5. Crawford ED, Mackenzie SH, Safford HR, Capriola M. PMID: 8648767.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    Elward's Networks
    Concepts (54)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (10)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California